19 results on '"Bos JD"'
Search Results
2. Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled pilot study.
- Author
-
Kroon MW, Wind BS, Beek JF, Wietze van der Veen JP, Nieuweboer-Krobotová L, Bos JD, Wolkerstorfer A, Kroon, Marije W, Wind, Bas S, Beek, Johan F, van der Veen, J P Wietze, Nieuweboer-Krobotová, Ludmila, Bos, Jan D, and Wolkerstorfer, Albert
- Abstract
Background: Various treatments are currently available for melasma. However, results are often disappointing.Objective: We sought to assess the efficacy and safety of nonablative 1550-nm fractional laser therapy and compare results with those obtained with triple topical therapy (the gold standard).Methods: Twenty female patients with moderate to severe melasma and Fitzpatrick skin types II to V were treated either with nonablative fractional laser therapy or triple topical therapy (hydroquinone 5%, tretinoin 0.05%, and triamcinolone acetonide 0.1% cream) once daily for 8 weeks in a randomized controlled observer-blinded study. Laser treatment was performed every 2 weeks for a total of 4 times. Physician Global Assessment was assessed at 3 weeks, 3 months, and 6 months after the last treatment.Results: Physician Global Assessment improved (P < .001) in both groups at 3 weeks. There was no difference in Physician Global Assessment between the two groups. Mean treatment satisfaction and recommendation were significantly higher in the laser group at 3 weeks (P < .05). However, melasma recurred in 5 patients in both groups after 6 months. Side effects in the laser group were erythema, burning sensation, facial edema, and pain; in the triple group side effects were erythema, burning, and scaling.Limitations: Limitations were: small number of patients; only one set of laser parameters; and a possible difference in motivation between groups.Conclusions: Nonablative fractional laser therapy is safe and comparable in efficacy and recurrence rate with triple topical therapy. It may be a useful alternative treatment option for melasma when topical bleaching is ineffective or not tolerated. Different laser settings and long-term maintenance treatment should be tested in future studies. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
3. The burden of vitiligo: patient characteristics associated with quality of life.
- Author
-
Linthorst Homan MW, Spuls PI, de Korte J, Bos JD, Sprangers MA, and van der Veen JP
- Subjects
- Adolescent, Adult, Aged, Emotions, Female, Health Status, Humans, Linear Models, Male, Middle Aged, Multivariate Analysis, Psychology, Surveys and Questionnaires, Young Adult, Cost of Illness, Quality of Life, Vitiligo psychology
- Abstract
Background: Vitiligo is commonly regarded as a harmless cosmetic skin problem in Western societies, and the importance of treating patients with vitiligo is often underestimated., Objective: We sought to determine the clinical and sociodemographic variables that adversely affect the quality of life in adult patients with generalized vitiligo so that these variables can be considered in the treatment and care., Methods: A total of 245 adult patients with generalized vitiligo completed two quality-of-life questionnaires (the Medical Outcomes Study 36-Item Short-form General Health Survey and the Skindex-29). Physicians assessed sociodemographic and clinical characteristics of these patients., Results: Dark skin type, vitiligo located on the chest, and treatment in the past appeared to have an adverse impact on the psychosocial domains of quality of life. Moreover, itch was reported by 20% of the patients in this study., Limitations: Psychiatric comorbidity was not evaluated in the analyses., Conclusion: Generalized vitiligo is a serious skin disorder with an adverse impact on the emotional state, comparable with that of other major skin diseases.
- Published
- 2009
- Full Text
- View/download PDF
4. Clinical differences between atopic and atopiform dermatitis.
- Author
-
Brenninkmeijer EE, Spuls PI, Legierse CM, Lindeboom R, Smitt JH, and Bos JD
- Subjects
- Adolescent, Adult, Case-Control Studies, Dermatitis, Atopic immunology, Dermatitis, Atopic physiopathology, Diagnosis, Differential, Female, Humans, Male, Medical Records, Quality of Life, Severity of Illness Index, Allergens immunology, Dermatitis, Atopic classification, Dermatitis, Atopic diagnosis, Epitopes, Immunoglobulin E blood
- Abstract
Background: Atopic dermatitis (AD) has been divided into the "extrinsic" and "intrinsic" type, in which "intrinsic AD" is characterized by the absence of allergen-specific IgE. Still, there is no consensus whether this "intrinsic type" of AD, which we denominate as atopiform dermatitis (AFD), is a distinct entity., Objective: A case-control study was performed to compare the clinical and diagnostic features of AD and AFD., Methods: Patients with a clinical diagnosis of AD were selected. Cases did not have demonstrable allergen-specific IgE. Matched control subjects were tested positive for allergen-specific IgE. Patients were evaluated for medical history, quality of life, disease severity, and Hanifin and Rajka, U.K. and Millennium diagnostic criteria., Results: Eight percent (n = 34) of the selected patients had, in fact, AFD. Female predominance, absence of atopic diseases, later onset of disease, and milder disease severity were observed in AFD. A history of atopy, recurrent conjunctivitis, palmar hyperlinearity, keratosis pilaris, pityriasis alba, and hand and/or food eczema were significantly less present in AFD. Dennie-Morgan fold was positively associated with AFD., Limitations: Not all patients with negative allergen-specific IgE participated and a relatively small number of AFD patients were studied., Conclusions: In addition to the absence of allergen-specific IgE, our findings support that AFD is an entity distinct from AD. With a distinction shown between AFD and AD, patient groups will be better defined and more homogeneous. Implications of this distinction will be of importance for preventive and therapeutic advice; diagnostic processes; and for future research.
- Published
- 2008
- Full Text
- View/download PDF
5. Psoriasis, innate immunity, and gene pools.
- Author
-
Bos JD
- Subjects
- Alleles, Gene Amplification, Humans, Polymorphism, Genetic, Population Groups genetics, Gene Pool, Immunity, Innate genetics, Psoriasis genetics, Psoriasis immunology
- Abstract
Recently, emphasis has shifted from T cells to innate (natural) immunity as the possible major culprit in psoriasis. All known elements of innate immune responses are up-regulated in psoriasis lesions, which must have a polygenetic origin. We hypothesize that urbanized populations have been under evolutionary pressure that selects for increased innate immunity responses because those offer relative but immediate protection from epidemic infections. That would have resulted in a changing gene pool, in which alleles of polymorphisms associated with increased innate immunity responses have amplified in these populations. Having too many of these genes together in one individual would result in a relatively low number of infections. On the other hand, it would also result in a higher prevalence of diseases related to increased innate immunity, such as psoriasis, and perhaps also multiple sclerosis and rheumatoid arthritis. Indeed, in indigenous people (Inuit, Aborigines, Ami) who have not been under this selection pressure, morbidity due to infections is high and the prevalence of psoriasis is low or even absent.
- Published
- 2007
- Full Text
- View/download PDF
6. Benzoyl peroxide/clindamycin/UVA is more effective than fluticasone/UVA in progressive macular hypomelanosis: a randomized study.
- Author
-
Relyveld GN, Kingswijk MM, Reitsma JB, Menke HE, Bos JD, and Westerhof W
- Subjects
- Administration, Topical, Adult, Androstadienes adverse effects, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents adverse effects, Anti-Inflammatory Agents adverse effects, Benzoyl Peroxide administration & dosage, Benzoyl Peroxide adverse effects, Clindamycin administration & dosage, Clindamycin adverse effects, Disease Progression, Female, Fluticasone, Humans, Hydrogels, Hypopigmentation drug therapy, Hypopigmentation pathology, Male, Treatment Outcome, Androstadienes therapeutic use, Anti-Bacterial Agents therapeutic use, Anti-Inflammatory Agents therapeutic use, Benzoyl Peroxide therapeutic use, Clindamycin therapeutic use, Hypopigmentation therapy, Ultraviolet Therapy
- Abstract
Background: There is no effective treatment for progressive macular hypomelanosis. Recent findings indicate that Propionibacterium acnes may play a role in the pathogenesis., Objectives: We sought to compare the effectiveness of antimicrobial therapy with anti-inflammatory therapy in patients with progressive macular hypomelanosis., Methods: A total of 45 patients were randomized to a within-patient left-right comparison study of benzoyl peroxide 5% hydrogel/clindamycin 1% lotion in combination with UVA irradiation versus fluticasone 0.05% cream in combination with UVA irradiation. Repigmentation was determined by photometric measurements of changes in skin color and by patient and dermatologist assessment using before and after photographs., Results: Benzoyl peroxide 5% hydrogel, clindamycin 1% lotion, and UVA led to better repigmentation than fluticasone 0.05% cream in combination with UVA irradiation in all measurements. (Photometric measurements P = .007, patient assessment P < .0001, and dermatologist assessment P < .0001.), Limitations: There was difficult objective color measurement. Therefore, subjective assessment has important additional value. Right-left comparisons have certain inherent limitations., Conclusion: Antimicrobial therapy in conjunction with light was more effective in repigmentation in patients with progressive macular hypomelanosis than a combination of anti-inflammatory therapy and light.
- Published
- 2006
- Full Text
- View/download PDF
7. Long-term management of plaque psoriasis with continuous efalizumab therapy.
- Author
-
Menter A, Leonardi CL, Sterry W, Bos JD, and Papp KA
- Subjects
- Antibodies, Monoclonal, Humanized, Clinical Trials as Topic, Humans, Quality of Life, Treatment Outcome, Antibodies, Monoclonal administration & dosage, Immunologic Factors administration & dosage, Psoriasis drug therapy
- Published
- 2006
- Full Text
- View/download PDF
8. Increased incidence of hypercoagulability in patients with leg ulcers caused by leukocytoclastic vasculitis.
- Author
-
Mekkes JR, Loots MA, van der Wal AC, and Bos JD
- Subjects
- Female, Humans, Incidence, Male, Middle Aged, Thrombophilia etiology, Leg Ulcer etiology, Thrombophilia epidemiology, Vasculitis, Leukocytoclastic, Cutaneous complications
- Abstract
Vasculitis is a rare cause of leg ulceration. It is unclear why severe skin infarction develops in some patients with vasculitis, whereas others have only mild symptoms such as purpura, erythema, or urticaria. A coincidence of vasculitis and hypercoagulability may lead to more extensive thrombotic occlusion and hence explain the occurrence of large ulcers in a subset of patients. Our aim was to investigate whether patients with vasculitis ulcers have an increased incidence of hypercoagulability. Thirteen consecutive patients admitted to the hospital with necrotic ulcers caused by histologically confirmed vasculitis were screened for clotting disorders. In 7 of 13 patients (53%), hypercoagulable conditions were found. Five patients had factor V Leiden (38%), and 2 had lupus anticoagulant (15%). The normal frequency of these conditions is 5% to 6% and 3.6%, respectively. These data indicate that there is an increased incidence of hypercoagulable disorders in patients with vasculitis ulcers. We recommend screening these patients routinely for hypercoagulability.
- Published
- 2004
- Full Text
- View/download PDF
9. Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: A systematic review.
- Author
-
Kozel MM, Bossuyt PM, Mekkes JR, and Bos JD
- Subjects
- Chronic Disease, Clinical Laboratory Techniques, Diagnosis, Differential, Female, Humans, Male, Sensitivity and Specificity, Angioedema diagnosis, Urticaria diagnosis
- Abstract
Background: The value of laboratory tests in chronic urticaria is still controversial., Objective: Our aim was to assess this value in clinical studies, and to identify factors explaining the variation in the number of identified causes., Methods: A total of 4 electronic databases were searched, and a manual literature search was performed. Only unselected patient series with more than 50 adult patients were included. From each included study predefined items were recorded to assess their quality (consecutive patients, use of standardized diagnostic criteria) and validity (follow-up, assessment of treatment effects, level of evidence)., Results: A total of 29 studies were included, involving 6462 patients. The verification of the validity of the results and the level of evidence of the included studies were limited., Conclusion: No relationship between the number of identified diagnoses and the number of performed laboratory tests, the different settings, the study design, or the publication period was found. On the basis of this systematic review and the relevant literature, a clinical guideline in the form of a flowchart is presented.
- Published
- 2003
- Full Text
- View/download PDF
10. Natural course of physical and chronic urticaria and angioedema in 220 patients.
- Author
-
Kozel MM, Mekkes JR, Bossuyt PM, and Bos JD
- Subjects
- Adolescent, Adult, Aged, Chronic Disease, Cohort Studies, Female, Humans, Longitudinal Studies, Male, Middle Aged, Practice Guidelines as Topic, Prognosis, Prospective Studies, Remission, Spontaneous, Surveys and Questionnaires, Angioedema pathology, Urticaria pathology
- Abstract
Background: Information about spontaneous remission of chronic urticaria is limited., Objective: To investigate the natural course of urticaria, we followed up 220 adults in a prospective study., Methods: Patients were followed up for 1 to 3 years to evaluate interventions, to detect latent causes, and to study the natural course of urticaria. The diagnosis was made by detailed history-taking as well as laboratory and provocation tests., Results: Thirty-five percent of all patients were free of symptoms after 1 year. In 28.9% of patients, symptoms had decreased. Spontaneous remission occurred in 47.4% of the patients in whom no cause of their urticaria and/or angioedema could be identified and in only 16.4% of the patients with physical urticaria. A cause could be identified in 53.1% of the patients. Thirty-six percent of the patients had idiopathic urticaria. Chronic idiopathic urticaria combined with physical urticaria occurred in 10.9%., Conclusion: In general, the prognosis for spontaneous remission is reasonable, with the exception of the subgroup (33.2%) with physical urticaria.
- Published
- 2001
- Full Text
- View/download PDF
11. Photochemotherapy for systemic and localized scleroderma.
- Author
-
De Rie MA and Bos JD
- Subjects
- Humans, Photochemotherapy, Scleroderma, Localized drug therapy, Scleroderma, Systemic drug therapy
- Published
- 2000
- Full Text
- View/download PDF
12. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy.
- Author
-
Njoo MD, Bos JD, and Westerhof W
- Subjects
- Child, Female, Humans, Male, Patient Compliance, Quality of Life, Treatment Outcome, Ultraviolet Therapy, Vitiligo radiotherapy
- Abstract
Background: Only a few clinical trials have been performed on the treatment of generalized vitiligo in children. Recently, narrow-band UVB therapy has been reported to be an effective and safe therapeutic option in adult patients with vitiligo., Objective: We studied the efficacy and safety of UVB (311 nm) therapy in children with generalized vitiligo and evaluated the effect of the therapy on the quality of life in these children., Methods: In an open trial, 51 children (20 males, 31 females) with generalized vitiligo were treated twice weekly with narrow-band UVB radiation therapy for the maximum period of 1 year. The Children's Dermatology Life Quality Index (CDLQI) was used to evaluate the psychosocial impact of disease and treatment and was scored before and after therapy., Results: The treatment resulted in more than 75% overall repigmentation in 53% of patients and in stabilization of the disease in 80%. Responsiveness to therapy was positively correlated with localization of the lesions and the patients' compliance. Adverse events were limited and transient. The better the repigmentation grade, the better the CDLQI scores had improved., Conclusion: Narrow-band UVB therapy is effective and safe in childhood vitiligo; it also may significantly improve the quality of life.
- Published
- 2000
- Full Text
- View/download PDF
13. Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis).
- Author
-
Enomoto DN, Mekkes JR, Bossuyt PM, Yong SL, Out TA, Hoekzema R, de Rie MA, Schellekens PT, ten Berge IJ, de Borgie CA, and Bos JD
- Subjects
- Adult, Aged, Aged, 80 and over, Cross-Over Studies, Female, Humans, Male, Middle Aged, Treatment Outcome, Photopheresis, Scleroderma, Systemic therapy
- Abstract
Background: Effective treatment modalities for systemic sclerosis, a life-threatening and disabling disease, are still lacking. Possible efficacy of photopheresis has been reported in several studies. Because of the complexity of the treatment, placebo-controlled trials are difficult to perform., Objective: We investigated the effect of photopheresis on clinical parameters (skin score and internal organ functions), immunologic parameters, and quality of life., Methods: Nineteen patients with progressive systemic sclerosis of less than 5 years' duration were randomized into 2 groups. One group (group A) received photopheresis for 1 year, the other group (group B) received no treatment at all. After 1 year the groups switched (crossover design). Photopheresis was performed on 2 consecutive days every 4 weeks; the psoralens were administered parenterally. The main outcome parameter was the skin score after 1 year of treatment compared with that of the control group., Results: The average skin score improved with 5.4% (standard error [SE], 20. 8%) in group A and deteriorated with 4.5% (SE, 13.8%) in group B (not significant; P =.71). Before crossover, the average increase in skin score was 5.3% (means of entire group). No change was observed in other clinical parameters. Approximately 1 year after crossover, the skin score reversed to what would have been expected with an average increase of 5.3% per year. There was also no effect on immunologic parameters. Quality of life did not change during treatment., Conclusion: We were not able to show that photopheresis, performed as described above, is an effective treatment in systemic sclerosis. The difference in average skin score was statistically and clinically insignificant. Despite the small sample size, we concluded that the magnitude of the observed changes is too small to justify photopheresis as a regular treatment.
- Published
- 1999
- Full Text
- View/download PDF
14. No additional effect of calcipotriol ointment on low-dose narrow-band UVB phototherapy in psoriasis.
- Author
-
Brands S, Brakman M, Bos JD, and de Rie MA
- Subjects
- Adolescent, Adult, Aged, Calcitriol therapeutic use, Female, Humans, Male, Middle Aged, Psoriasis drug therapy, Single-Blind Method, Treatment Outcome, Calcitriol analogs & derivatives, Dermatologic Agents therapeutic use, Phototherapy methods, Psoriasis therapy
- Abstract
Background: Broad-band UVB phototherapy has appeared to be effective in clearing psoriatic lesions. After the advent of calcipotriol ointment, promising results have been obtained by combining these two therapeutic modalities. Also, an additional effect of narrow-band UVB phototherapy on treatment with calcipotriol ointment has been demonstrated., Objective: Our purpose was to compare treatment with low-dose narrow-band UVB phototherapy both with and without calcipotriol ointment., Methods: We included 53 patients suffering from plaque-type psoriasis. All patients underwent low-dose narrow-band UVB phototherapy. Nearly half of the patients were randomized to apply calcipotriol ointment (50 microg/g) twice daily on the affected skin. The Psoriasis Area and Severity Index (PASI) was used to evaluate psoriatic lesions., Results: In this study we showed that low-dose narrow-band UVB phototherapy is effective in the treatment of psoriasis and that calcipotriol ointment does not improve treatment outcome., Conclusion: Calcipotriol ointment does not improve treatment with low-dose narrow-band UVB phototherapy.
- Published
- 1999
- Full Text
- View/download PDF
15. Ranitidine does not affect psoriasis: a multicenter, double-blind, placebo-controlled study.
- Author
-
Zonneveld IM, Meinardi MM, Karlsmark T, Johansen UB, Kuiters GR, Hamminga L, Staberg B, van't Veen AJ, Bossuyt PM, van Niel JC, and Bos JD
- Subjects
- Adult, Double-Blind Method, Female, Humans, Male, Middle Aged, Histamine H2 Antagonists administration & dosage, Psoriasis drug therapy, Ranitidine administration & dosage
- Abstract
Background: Data from open studies suggest that ranitidine has a beneficial effect on psoriasis and is well tolerated., Objective: Our purpose was to determine the effectiveness of ranitidine in a 24-week, multicenter, double-blind, placebo-controlled, dose-comparing study of 201 patients with psoriasis., Methods: Patients with moderate to severe psoriasis who had stopped systemic antipsoriatic therapy, including PUVA and UVB, for at least 10 weeks were included. After a washout period of 2 weeks, patients were randomly allocated to use either ranitidine, 150 mg twice a day; ranitidine, 300 mg twice a day; or placebo for up to 24 weeks. Assessment with the Psoriasis Area and Severity Index was performed at weeks 3, 6, 9, 12, 18, and 24 after randomization. Reduction of the Psoriasis Area and Severity Index score by 70% at the completion of the study was considered a treatment success., Results: The success rates at week 24 in the 300 mg, 600 mg, and placebo groups were 11%, 5%, and 12%, respectively. No significant differences were observed between the three treatment groups at any stage of the study., Conclusion: This study provides strong evidence that ranitidine does not affect the skin disease in patients with psoriasis.
- Published
- 1997
- Full Text
- View/download PDF
16. Quantification of cutaneous sclerosis with a skin elasticity meter in patients with generalized scleroderma.
- Author
-
Enomoto DN, Mekkes JR, Bossuyt PM, Hoekzema R, and Bos JD
- Subjects
- Adult, Aged, Dermatology instrumentation, Elasticity, Equipment Design, Female, Humans, Linear Models, Middle Aged, Observer Variation, Reproducibility of Results, Scleroderma, Systemic pathology, Sclerosis, Skin pathology, Surface Properties, Vacuum, Scleroderma, Systemic physiopathology, Skin physiopathology
- Abstract
Background: The skin score, a subjective assessment of skin elasticity, is widely used in patients with systemic sclerosis. Although this scoring method is regarded as a validated and accepted tool, the interobserver and intraobserver reproducibility is relatively poor., Objective: Our purpose was to investigate whether the recently developed SEM 474 cutometer, which exerts a controlled vacuum force to the skin, can measure skin elasticity more objectively than the skin score., Methods: Skin elasticity was measured in 74 different body areas in patients with systemic sclerosis and compared with the skin score obtained from the same areas., Results: The cutometer produced quantitative and reproducible data. A large-diameter (8 mm) measuring probe was superior to a small probe. The interobserver intraclass correlation coefficient (ICC) was 0.92; the intraobserver ICC was 0.94. A linear correlation was found with the clinical skin score; the Spearman rank correlation test was 0.69., Conclusion: The correlation with the skin score was reasonable, despite the observation that regional differences in skin elasticity were detected by the cutometer but not by the human observer, who automatically compensates for these factors and integrates them into the skin score. The high interobserver and intraobserver ICC makes the cutometer more suitable for quantifying changes in skin thickness than the subjective skin score.
- Published
- 1996
- Full Text
- View/download PDF
17. Repigmentation in vitiligo vulgaris by autologous minigrafting: results in nineteen patients.
- Author
-
Boersma BR, Westerhof W, and Bos JD
- Subjects
- Adolescent, Adult, Bandages, Chronic Disease, Evaluation Studies as Topic, Female, Follow-Up Studies, Humans, Male, Middle Aged, Signal Processing, Computer-Assisted, Time Factors, Transplantation, Autologous, Treatment Outcome, Video Recording, Vitiligo diagnosis, Skin Pigmentation, Skin Transplantation methods, Vitiligo surgery
- Abstract
Background: Minigrafting is a successful therapy for localized vitiligo but has never been reported for vitiligo vulgaris., Objective: Our purpose was to evaluate the efficacy of minigrafting in vitiligo vulgaris., Methods: In 59 patients with stable vitiligo vulgaris, a minigraft test was done by implanting two minigrafts in the lesion to be grafted. Patients were selected for grafting when spread of pigment was observed within 3 months. The rate of repigmentation was evaluated by digital image analysis., Results: Twenty-three patients (36 lesions), of 24 with a positive minigraft test, were grafted. The results of 19 patients were analyzed, showing 80% to 99% repigmentation in 14 lesions, 50% to 80% repigmentation in 10 lesions, and zero to 50% repigmentation in 12 lesions. Time of observation varied from 3 to 12 months after grafting. Best results were observed after 9 to 12 months. In all patients with a positive Koebner phenomenon depigmentation of the minigrafts developed., Conclusion: Autologous minigrafting is an effective therapy for stable vitiligo vulgaris in a selected group of patients.
- Published
- 1995
- Full Text
- View/download PDF
18. An open prospective clinical trial with systemic ranitidine in the treatment of psoriasis.
- Author
-
Witkamp L, Velthuis PJ, Verhaegh ME, Hulsmans RF, Bossuyt PM, Bos JD, and Meinardi MM
- Subjects
- Administration, Oral, Adolescent, Adult, Aged, Female, Humans, Male, Middle Aged, Prospective Studies, Psoriasis pathology, Ranitidine administration & dosage, Remission Induction, Time Factors, Psoriasis drug therapy, Ranitidine therapeutic use
- Published
- 1993
- Full Text
- View/download PDF
19. Two distinct squamous cell carcinomas in a psoriasis patient receiving low-dose cyclosporine maintenance treatment.
- Author
-
Bos JD and Meinardi MM
- Subjects
- Female, Humans, Middle Aged, Carcinoma, Squamous Cell etiology, Cyclosporins adverse effects, Neoplasms, Multiple Primary, Psoriasis drug therapy, Skin Neoplasms etiology
- Published
- 1989
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.